anti-XAGE1A antibody product blog
Tags: Antibody; Polyclonal Antibody; XAGE1A; XAGE1; anti-XAGE1A antibody;
The XAGE1A xage1a (Catalog #MBS6002657) is an Antibody produced from Goat and is intended for research purposes only. The product is available for immediate purchase. The XAGE1 (G Antigen Family D Member 2, Cancer/Testis Antigen 12.1, CT12.1, Protein XAGE-1, XAGE1A, GAGED2, XAGE1B, XAGE1C, XAGE1D, XAGE1E) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s XAGE1 can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA).Suitable for use in ELISA.
Dilution: ELISA: 1:8000. Researchers should empirically determine the suitability of the XAGE1A xage1a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The XAGE1A xage1a product has the following accession number(s) (GI #284055227) (NCBI Accession #NP_001091061.2) (Uniprot Accession #Q9HD64). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
XAGE1 is a member of the XAGE subfamily, which belongs to the GAGE family. The GAGE genes are expressed in a variety of tumors and in some fetal and reproductive tissues. XAGE1 is strongly expressed in Ewing\'s sarcoma, alveolar rhabdomyosarcoma and normal testis. XAGE1 contains a nuclear localization signal and shares a sequence similarity with other GAGE/PAGE proteins. Because of the expression pattern and the sequence similarity, this protein also belongs to a family of CT (cancer-testis) antigens. Alternative splicing of XAGE1 generates 3 transcript variants, and one of which includes 2 transcripts generated from alternate transcription initiation sites.
Immunogen: Synthetic peptide corresponding to CGFGFRRQGEDNT, from GAGED2, at C-terminal (NP_597673.1). In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing XAGE1A are readily searchable from our website. Different antibodies against the same target such as XAGE1A may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.